These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 7967208)

  • 21. Prevalence of HTLV-I-associated uveitis in the Kanto Plain, Japan.
    Ishioka M; Goto K; Nakamura S; Watanabe N; Uchio E; Saeki K; Ohno S
    Graefes Arch Clin Exp Ophthalmol; 1995 Aug; 233(8):476-8. PubMed ID: 8537021
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ocular manifestations in patients with HTLV-I associated infection--a clinical study of 93 cases.
    Merle H; Smadja D; Le Hoang P; Bera O; Cabre P; Landau M; Vernant JC
    Jpn J Ophthalmol; 1996; 40(2):260-70. PubMed ID: 8876397
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HTLV-I associated retinochoroidal degeneration.
    Ohba N; Nakao K; Isashiki Y
    Jpn J Ophthalmol; 1996; 40(1):71-8. PubMed ID: 8739503
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term progression, prognosis, and treatment of patients with recurrent ocular manifestations of Reiter's syndrome.
    Kiss S; Letko E; Qamruddin S; Baltatzis S; Foster CS
    Ophthalmology; 2003 Sep; 110(9):1764-9. PubMed ID: 13129875
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Myelopathy with uveitis in association with HTLV-I mimicking neuro-Behçet's disease].
    Saito Y; Ando T; Kameyama T; Takahashi A; Horiguchi M
    Rinsho Shinkeigaku; 1993 Aug; 33(8):912-4. PubMed ID: 8261708
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Disappearance of puncta after uveitis in an eye with fundus albipunctatus.
    Imaizumi M; Tatewaki SY; Kimoto K; Takaki Y; Nakatsuka K; Furushima M; Matsumoto CS; Choshi T
    Retina; 2005 Dec; 25(8):1096-8. PubMed ID: 16340543
    [No Abstract]   [Full Text] [Related]  

  • 27. Immunologic and virologic characterization of the primary infiltrating cells in the aqueous humor of human T-cell leukemia virus type-1 uveitis. Accumulation of the human T-cell leukemia virus type-1-infected cells and constitutive expression of viral and interleukin-6 messenger ribonucleic acids.
    Ono A; Mochizuki M; Yamaguchi K; Miyata N; Watanabe T
    Invest Ophthalmol Vis Sci; 1997 Mar; 38(3):676-89. PubMed ID: 9071222
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Seroprevalence of HTLV-I in various ocular diseases in central Japan].
    Goto K; Kurita M; Watanabe N; Ogi A; Iijima Y; Hanajiri M; Saeki K; Ohno S
    Nippon Ganka Gakkai Zasshi; 1995 Aug; 99(8):959-63. PubMed ID: 7676898
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Subretinal neovascular membranes complicating uveitis: frequency, treatments, and visual outcome.
    Perentes Y; Van Tran T; Sickenberg M; Herbort CP
    Ocul Immunol Inflamm; 2005; 13(2-3):219-24. PubMed ID: 16019682
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Uveitis in Behçet disease: an analysis of 880 patients.
    Tugal-Tutkun I; Onal S; Altan-Yaycioglu R; Huseyin Altunbas H; Urgancioglu M
    Am J Ophthalmol; 2004 Sep; 138(3):373-80. PubMed ID: 15364218
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human T-lymphotropic virus type I-associated uveitis in patients with Graves' disease treated with methylmercaptoimidazole.
    Mizokami T; Okamura K; Kohno T; Sato K; Ikenoue H; Kuroda T; Inokuchi K; Fujishima M
    J Clin Endocrinol Metab; 1995 Jun; 80(6):1904-7. PubMed ID: 7775639
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunologic markers, uveitis, and keratoconjunctivitis sicca associated with human T-cell lymphotropic virus type 1.
    Pinheiro SR; Martins-Filho OA; Ribas JG; Catalan-Soares BC; Proietti FA; Namen-Lopes S; Brito-Melo GE; Carneiro-Proietti AB;
    Am J Ophthalmol; 2006 Nov; 142(5):811-15. PubMed ID: 16989761
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Severe graves ophthalmopathy accompanied by HTLV-1-associated uveitis (HAU) and anti-neutrophil cytoplasmic antibody-related vasculitis: a case report and a review of the literature of HAU with Graves disease.
    Sarui H; Sano A; Maruyama T; Nakashima K; Takeda N; Yasuda K
    Am J Med Sci; 2002 Aug; 324(2):109-14. PubMed ID: 12186105
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HTLV-I associated uveitis revisited: characteristic grey-white, granular deposits on retinal vessels.
    Nakao K; Ohba N
    Br J Ophthalmol; 1996 Aug; 80(8):719-22. PubMed ID: 8949716
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical features in tubulointerstitial nephritis and uveitis (TINU) syndrome.
    Goda C; Kotake S; Ichiishi A; Namba K; Kitaichi N; Ohno S
    Am J Ophthalmol; 2005 Oct; 140(4):637-41. PubMed ID: 16226516
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Human T-lymphotropic virus type 1 uveitis in children].
    Kihara K; Tsuruda M; Ono A; Ikeda E; Hikita N; Miyata N; Mochizuki M
    Nippon Ganka Gakkai Zasshi; 1997 Jun; 101(6):538-43. PubMed ID: 9209144
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Determination of anti-HTLV-I/II antibodies: Experience in 28,897 blood donations in Buenos Aires].
    Blejer JL; Saguier MC; Salamone HJ; Carreras LA
    Sangre (Barc); 1995 Dec; 40(6):447-51. PubMed ID: 8850226
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rubella virus-associated uveitis: clinical manifestations and visual prognosis.
    de Visser L; Braakenburg A; Rothova A; de Boer JH
    Am J Ophthalmol; 2008 Aug; 146(2):292-7. PubMed ID: 18547534
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Seroprevalence of antibodies to HTLV-I in patients with ocular disorders.
    Nakao K; Matsumoto M; Ohba N
    Br J Ophthalmol; 1991 Feb; 75(2):76-8. PubMed ID: 1995047
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [HTLV-I and ocular disease].
    Ohba N; Nakao K
    Nippon Ganka Gakkai Zasshi; 1993 Apr; 97(4):433-40. PubMed ID: 8317363
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.